Methylguanine methyltransferase testing in glioblastoma: when and how?
Stupp
Roger
R
Hegi
Monika E
ME
D014408:Biomarkers, Tumor / Q000032:analysis / Q000378:metabolism*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D005909:Glioblastoma / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000032:analysis / Q000378:metabolism*; D011379:Prognosis; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D015996:Survival Rate; D000077204:Temozolomide
D014408:Biomarkers, Tumor; D003606:Dacarbazine; D019853:O(6)-Methylguanine-DNA Methyltransferase; D000077204:Temozolomide